Global Expansion and Strategic Adaptability: The Keytruda Market Regional Share
  The global presence of pembrolizumab is undergoing a significant geographic rebalancing as we move through 2026. While North America traditionally holds the largest Keytruda Market regional share at over 43%, the focus is rapidly shifting toward the European Union and the Asia-Pacific (APAC) region. In Europe, the European Medicines Agency (EMA) recently adopted a positive stance on a...
0 Comments 0 Shares 992 Views 0 Reviews